INM: InMed Pharmaceuticals Inc Company Profile & Statistics

About

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

Info & Links

CEO

Eric A. Adams

Headquarters

1445, 885 West Georgia St.
VANCOUVER, A1 V6C 3E8, CANADA

Auditor

Marcum LLP

Share holders

11,764

Employees

InMed Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

3.53M

Enterprise Value

-997.00K

Enterprise Value/EBITDA(ttm)

0.14

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.63

Price to Book(mrq)

0.34

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

31.54%

Operating Margin(ttm)

-137.41%

Profit Margin(ttm)

-137.45%

Return on Equity(ttm)

-65.74%

Return on Invested Capital(ttm)

-63.71%

Return on Assets(ttm)

-53.57%

Income Statement

Revenue(ttm)

4.96M

Revenue Per Share(ttm)

138.17

Gross Profit(ttm)

1.57M

EBITDA(ttm)³

-7.04M

Net Income Available to Common(ttm)

-6.82M

Diluted EPS(ttm)

-13.91

Share Statistics

Beta (5Y Monthly)

0.23

52-Week Change

-41.44%

S&P 500 52-Week Change

23.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

35.90K

Dividend Yield

0.00%

Float⁴

711.00K

% Held by Insiders

1.85%

% Held by Institutions

20.12%

Balance Sheet

Total Cash(mrq)

5.63M

Total Cash Per Share(mrq)

156.71

Total Debt(mrq)

1.06M

Total Debt/Equity(mrq)

12.60%

Current Ratio(mrq)

5.07%

Quick Ratio(mrq)

4.22%

Book Value Per Share(mrq)

251.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-58.92

Free Cash Flow(ytd)

-1.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

INM

InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc Profile